| Literature DB >> 31442408 |
Saurav Roy Choudhury1, Liane Babes2, Jennifer J Rahn1, Bo-Young Ahn1, Kimberly-Ann R Goring1, Jennifer C King1, Arthur Lau3, Björn Petri4, Xiaoguang Hao1, Andrew K Chojnacki3, Ajitha Thanabalasuriar3, Erin F McAvoy3, Sébastien Tabariès5, Christoph Schraeder6, Kamala D Patel7, Peter M Siegel5, Karen A Kopciuk8, David C Schriemer6, Daniel A Muruve9, Margaret M Kelly10, Bryan G Yipp11, Paul Kubes7, Stephen M Robbins12, Donna L Senger13.
Abstract
A hallmark feature of inflammation is the orchestrated recruitment of neutrophils from the bloodstream into inflamed tissue. Although selectins and integrins mediate recruitment in many tissues, they have a minimal role in the lungs and liver. Exploiting an unbiased in vivo functional screen, we identified a lung and liver homing peptide that functionally abrogates neutrophil recruitment to these organs. Using biochemical, genetic, and confocal intravital imaging approaches, we identified dipeptidase-1 (DPEP1) as the target and established its role as a physical adhesion receptor for neutrophil sequestration independent of its enzymatic activity. Importantly, genetic ablation or functional peptide blocking of DPEP1 significantly reduced neutrophil recruitment to the lungs and liver and provided improved survival in models of endotoxemia. Our data establish DPEP1 as a major adhesion receptor on the lung and liver endothelium and identify a therapeutic target for neutrophil-driven inflammatory diseases of the lungs.Entities:
Keywords: ALI; acute lung injury; adhesion receptor; cell adhesion; dipeptidase-1 (DPEP1); endothelium; endotoxemia; intravital imaging; lung vasculature; neutrophil recruitment; sepsis
Mesh:
Substances:
Year: 2019 PMID: 31442408 DOI: 10.1016/j.cell.2019.07.017
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582